Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Lupus ; 21(10): 1098-104, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22577117

RESUMEN

The objective of this study was to explore the relationship between serum levels of ß2-microglobulin (ß2MG), which some studies suggest reflect disease activity in systemic lupus erythematosus (SLE), and various clinical and immunological markers of disease activity in SLE. Twenty-six SLE patients and 10 healthy controls were included. Disease activity was assessed by: SLEDAI, 24 hr-proteinuria, circulating levels of complement C3, anti-double-stranded DNA (anti-dsDNA), ß2MG and various pro-inflammatory and anti-inflammatory cytokines (IL-6, IL-8, IL-10, IL-18) measured with a multiplex assay, IFN-α assessed with a reporter gene assay, and a combined expression score of 12 IFN-α inducible genes in peripheral blood mononuclear cells. Median serum levels of ß2MG were significantly higher in SLE patients vs controls (2.8 mg/L, range: 1.1-21.6 and 1.2 mg/L, range: 0.9-1.7, respectively, p < 0.001). ß2MG was correlated with SLEDAI score (R = 0.68, p < 0.001), 24 hr-proteinuria (R = 0.64, p < 0.001), and complement C3 (R = -0.52, p = 0.007). The cytokines were significantly correlated with ß2MG: IL-6 (R = 0.45, p = 0.02), IL-8 (R = 0.75, p < 0.001), IL-10 (R = 0.67, p < 0.001) and IL-18 (R = 0.71, p < 0.001) as were serum IFN-α (R = 0.45, p = 0.02) and the IFN-α inducible gene-score (R = 0.51, p = 0.01). The results support that ß2MG may serve as a marker of disease activity in SLE. The correlations with the measured cytokines indicate that increased ß2MG in SLE reflects immunological activity.


Asunto(s)
Lupus Eritematoso Sistémico/sangre , Lupus Eritematoso Sistémico/inmunología , Microglobulina beta-2/metabolismo , Adulto , Anciano , Anticuerpos Antinucleares/sangre , Biomarcadores/sangre , Estudios de Casos y Controles , Complemento C3/metabolismo , Citocinas/sangre , Femenino , Expresión Génica , Humanos , Interferón-alfa/sangre , Lupus Eritematoso Sistémico/genética , Persona de Mediana Edad , Adulto Joven
2.
Br J Dermatol ; 160(2): 319-24, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19016708

RESUMEN

BACKGROUND: Th17 cells are a lineage of proinflammatory T helper cells producing interleukin (IL)-17. The importance of Th17 cells in inflammation and autoimmunity has now been recognized. The IL-17 cytokine family consists of six isoforms (IL-17A-IL-17F) whereas five members of the IL-17 receptor (IL-17R) family have been identified (IL-17RA-IL-17RE). OBJECTIVES: To characterize the expression of the IL-17 isoforms and receptors in lesional and nonlesional psoriatic skin. Methods Keratome and punch biopsies taken from patients with psoriasis were examined by enzyme-linked immunosorbent assay and quantitative reverse transcription-polymerase chain reaction in order to measure the IL-17 isoforms and receptors. RESULTS: We demonstrated significantly increased mRNA expression of IL-17A, IL-17C and IL-17F in psoriatic skin. In contrast, the mRNA expression of IL-17B and IL-17D was significantly decreased in lesional compared with nonlesional skin, while IL-17E mRNA was undetectable. The increased mRNA expression of IL-17A, IL-17C and IL-17F was paralleled by an increased protein accumulation of these cytokines in psoriatic skin. Analysis of the IL-17R mRNA expression revealed significantly impaired mRNA expression of IL-17RB, IL-17RC, IL-17RD and IL-17RE in lesional psoriatic skin, whereas the mRNA expression of IL-17RA was similar in lesional and nonlesional psoriatic skin. CONCLUSIONS: This study characterizes the mRNA profile of the IL-17 isoforms and receptors in psoriatic skin lesions. Furthermore, we demonstrate for the first time augmented protein levels of IL-17A, IL-17C and IL-17F in psoriatic skin lesions, indicating a possible role for IL-17C in addition to IL-17A and IL-17F in the pathogenesis of psoriasis.


Asunto(s)
Interleucina-17/metabolismo , Psoriasis/patología , ARN Mensajero/metabolismo , Receptores de Interleucina-17/metabolismo , Células Cultivadas , Expresión Génica , Humanos , Interleucina-17/genética , Isoformas de Proteínas/genética , Psoriasis/genética , Receptores de Interleucina-17/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transcripción Genética
3.
Scand J Immunol ; 64(1): 17-29, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16784487

RESUMEN

Human and mouse CD4(+)CD25(+) T cells have been intensively studied through the last decade. However, little is known about this subset in other species. This study describes the phenotype of rat CD4(+)CD25(+) Foxp3(+) T cells and the site in which they exert regulation in a transfer-induced autoimmune diabetes model. Several proteins and mRNAs are up-regulated in unstimulated rat CD4(+)CD25(+) T cells compared with CD4(+)CD25(-) T cells, including Foxp3, Lag-3, CD80, interleukin 10 (IL-10) and CTLA-4. To investigate CD4(+)CD25(+) T cells in vivo, we transferred three million diabetogenic T cells either alone or in combination with two million CD4(+)CD25(+) T cells to 30-day-old BB rats. The pancreas and the pancreatic lymph nodes were examined as two potential regulatory sites. Time-course analysis of pancreatic histology following diabetogenic T-cell transfers revealed insulitis from about 14 days after transfer. By contrast, rats receiving both diabetogenic T cells and CD4(+)CD25(+) T cells had no insulitis at any time. Moreover, the frequency of diabetogenic T cells in the pancreatic lymph nodes 2 days after transfer was significantly reduced in rats receiving both subsets. These data indicate that the primary site of T-cell regulation is in the draining lymph nodes and not the pancreas in our model.


Asunto(s)
Traslado Adoptivo , Diabetes Mellitus Tipo 1/inmunología , Islotes Pancreáticos/inmunología , Receptores de Interleucina-2/inmunología , Linfocitos T Reguladores/inmunología , Linfocitos T Reguladores/trasplante , Animales , Separación Celular , Regulación hacia Abajo , Factores de Transcripción Forkhead/biosíntesis , Inflamación , Islotes Pancreáticos/patología , Ganglios Linfáticos/inmunología , Páncreas/inmunología , Páncreas/patología , Páncreas/fisiopatología , Ratas , Ratas Endogámicas BB , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/trasplante
5.
J Hand Surg Am ; 1(2): 152-9, 1976 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1018080

RESUMEN

Patients with tetraplegia who have "strong" sixth cervical neurologic (C-6) function often can be given active grasp and strong lateral pinch by tendon transfers and tenodeses. Wrist control can be retained by the extensor carpi radialis brevis and flexor carpi radialis and can permit transfer of the extensor carpi radialis longus to provide finger flexion. Either the brachioradialis or pronator teres then is available for transfer to restore adduction-opposition of the thumb with an in situ tendon graft of a paralyzed flexor superficialis rerouted to the thumb through a palmar fascial pulley. The other motor can provide thumb flexion for strong lateral pinch. Extrinsic extension can be provided by tendoeses. With seventh cervical neurologic (C-7) function retained, active digital extension is present and functional expectations are better. Ten hands in seven patients with traumatic tetraplegia from injuries at C-6 or C-7 level have been reconstructed. The average grasp and pinch force after operation was 5.5 and 3.0 Kg., respectively. All patients but one were pleased with the increased function a


Asunto(s)
Mano/cirugía , Cuadriplejía/cirugía , Traumatismos de la Médula Espinal/complicaciones , Transferencia Tendinosa/métodos , Tendones/cirugía , Adolescente , Adulto , Femenino , Mano/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Cuadriplejía/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA